Xando Díaz-Villamarín

Visiting lecturer

Universidad de Granada

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Medical Science Medical Science professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Xando Díaz-Villamarín is a Visiting Lecturer at the University of Granada, Spain. His research focuses on clinical pharmacogenetics, pharmacokinetics, and the relationship between microbiome composition and disease severity. He has contributed to various studies on drug metabolism and adverse drug reactions, with recent publications addressing the implementation of pharmacogenomic-guided therapies.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Cinzia Dello Russo

Associate Professor of Pharmacology

Università Cattolica del Sacro Cuore Facoltà di Medicina e Chirurgia

ITALY

View details

Konstantinos Vasileiou

Assistant Professor

University of Patras

GREECE

View details

Alba Rodríguez

Assistant Professor

Universidad de Granada

SPAIN

View details

Manuel Colmenero

SPAIN

View details

Rocío García Orta

Cardiologist

Junta de Andalucía Servicio Andaluz de Salud

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Xando Díaz-Villamarín

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Clinical Pharmacogenetics: Results After Implementation of Preemptive Tests in Daily Routine

Dose-Limiting Toxicities and the Maximum Tolerated Dose of Irinotecan Based on UGT1A1 Genotypes: A Systematic Review

Pharmacokinetic/pharmacodynamic modeling in plasma and milk and Monte Carlo simulations of marbofloxacin against Staphylococcus aureus and Mycoplasma agalactiae in lactating sheep

The relationship between gut and nasopharyngeal microbiome composition can predict the severity of COVID-19

Selective Digestive Decontamination: A Comprehensive Approach to Reducing Nosocomial Infections and Antimicrobial Resistance in the ICU

Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

Pharmacogenetics of siponimod: A systematic review

Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients

Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients

Pharmacogenetic polymorphisms affecting bisoprolol response

Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis

Collaborators (5)

Cinzia Dello Russo

Konstantinos Vasileiou

Alba Rodríguez

Manuel Colmenero

Rocío García Orta

Make your next move.